Antibacterial Agents TRIZ Cases

Pure L-ergothioneine induces reactive oxygen species production in polymorphonuclear leukocytes to enhance immune responses.

Di-tert-butyl-4-methylphenol forms adducts with azole compounds to treat fungal infections while reducing cytotoxicity.

Phenylboronic acid groups anchor micelles to ocular mucin, overcoming rapid tear turnover barriers that limit traditional topical eye drop bioavailability.

Amphiphilic block copolymers encapsulate water-insoluble conjugated polymers into stable aqueous colloidal compositions.

Mitomycin C and cisplatin create DNA crosslinks to eradicate dormant bacterial persisters, resolving antibiotic tolerance in recalcitrant infections.

A 2-alkoxy[4,3:6,4-terpyridine]-3-carbonitrile compound inhibits bacterial and fungal growth through a terpyridine-coumarin hybrid structure.

Modified AdB-2/3 fiber polypeptides enhance desmoglein 2 affinity, disrupting tight junctions to deliver therapeutics to epithelial cancer cells.

Pectin coats resveratrol crystals to form granules, overcoming poor powder fluidization for tablet manufacturing.

Targeting conserved OppA and LapB proteins triggers a Th17 response that overcomes sequence variation to provide broad cross-strain protection.

Digestive enzymes degrade cell walls to treat resistant E. coli strains.

Novel pyridinone compounds inhibit the bacterial enzyme Fab I to block fatty acid biosynthesis.

Gamma cyclodextrin forms inclusion complexes with macrolides, preventing oxidative degradation and maintaining bioavailability.

Silicon-based siosomes replace unstable phospholipids to prevent drug leakage and enable autoclaving while inhibiting nucleic acid synthesis.

Bacillus subtilis strain PS-216 spores resist gastric conditions to reduce Campylobacter jejuni colonization and enhance broiler growth.

Aryl guanidine compounds inhibit mitochondrial F1F0-ATPases to selectively induce apoptosis in diseased cells, sparing healthy tissue and reducing resistance.

Morpholino oligonucleotides target conserved influenza viral RNA regions to inhibit replication, overcoming strain-specific vaccine limitations.

Recombinant chimeric proteins combined with non-metabolizable mineral oil adjuvants provide long-lasting immunity against contemporary West Nile Virus strains.

A beta-1,6-glucan composition enriched with O-acetyl groups stimulates antigen-specific immune responses.

Segmented molecules use protease cleavage to activate siRNA, ensuring gene suppression despite target mutations.

Novel azetidine derivatives modulate sphingosine-1-phosphate receptors to treat cardiovascular and inflammatory disorders.

A therapeutic antibody engineered with a specific glycosylation site resists enzymatic modification while endogenous serum antibodies are degraded.

Peptide sequences with cationic residues target bacterial membranes while sparing human cells, bypassing antibiotic resistance.

Formula I compounds enhance water solubility to combat resistant Mycobacterium tuberculosis strains.

Engineered microorganisms express heterologous antigens and transport systems to induce systemic cellular immune responses.

CATH2 derivatives induce trained immunity via TLR2 and TLR4 binding to amplify pro-inflammatory cytokine production against Salmonella enteritidis.

Combining succinic and aconitic acids in specific ratios resolves the contradiction between reliability and productivity, achieving significant biofilm removal.

Aptamer-regulated nucleic acid sensors switch conformational states upon ligand binding to enable sensitive analyte detection.

Direct nitric oxide administration into arterial blood generates S-nitrosylated hemoglobin, bypassing pulmonary inactivation to enable systemic vasodilation.

Site-specific proline substitutions in the H. pylori L1 peptide create an amphiphilic structure that disrupts bacterial membranes without causing cytotoxicity.

An SIRT1 expression inducer composition modulates immune responses by reducing pro-inflammatory cytokines and increasing anti-inflammatory cytokines.

Segmented VL constructs with localized mutations boost catalytic activity while Fc linkage extends circulation half-life.

A plant composition combining lemon eucalyptus, lavender, and mint delivers sustained mosquito repellency through synergistic essential oil interactions.

High-throughput DNA sequencing determines relative bacterial abundance in fecal samples to identify bloodstream infection risks.

A trimerizing peptide binds minor pilin to block bacterial adhesion in digestive organs.

Isolated bacteriophage lyses Salmonella Gallinarum and Pullorum cells to prevent antibiotic resistance and egg-transmitted disease spread.

Segmented stable precursors resolve the contradiction between chemical stability and antioxidant activity, extending shelf life while maintaining efficacy.

Human beta-defensin peptide inhibits bacterial growth and reduces inflammation markers without triggering antibiotic resistance or severe steroid side effects.

Ionizable lipid liposomes encapsulate RNA to protect it from degradation and enable efficient protein expression for immunization.

Immunogenic composition combining NmC oligosaccharide conjugated to carrier proteins with NmB outer membrane protein antigens.

Specific structural parameters in omega-cyclohexylalkan-1-oles resolve contradictions between antimicrobial efficacy, stability, and skin compatibility.

Zinc compound solution modifies allograft tissue surface to inhibit microbial organisms, reducing bacterial infections by up to 99.99%.

Cationic steroidal compounds replace peptide bonds to eliminate protease susceptibility while maintaining broad-spectrum antibacterial efficacy.

Replacing methoxyl terminal groups with hydroxyls in polyalkylene glycol lowers antigenicity and immunogenicity while extending protein circulation half-life.